[Trump Reportedly Plans to Impose New Tariffs on Certain Pharmaceutical Companies] Jin10 News, April 2 – According to informed sources, the Trump administration is expected to announce as early as Thursday local time that it will impose tariffs on pharmaceutical companies that have not yet reached agreements to ensure low-priced sales in the U.S. This marks the latest move to levy tariffs on imported goods under the guise of national security. Over the past year, Trump has repeatedly threatened to impose tariffs on the pharmaceutical industry, with rates potentially ranging from 100% to 200%. The goal is to pressure pharmaceutical companies to relocate manufacturing back to the U.S. and reduce drug prices for American patients. Most major pharmaceutical companies, including Pfizer and Eli Lilly, have reached agreements with the White House in exchange for a three-year exemption from such tariffs. According to informed sources, the new tariffs stem from an investigation conducted under Section 232 of the Trade Expansion Act of 1962. Companies that have not reached agreements or engaged in negotiations with the government will face a 100% tariff. The sources noted that the plan has not been finalized and is still subject to change. They also mentioned that certain drugs and disease categories may be granted exemptions.